Search

everythinglearnresearchcommunity

for

Search:↓

Pioglitazone usually doesn't effectively treat or cure lichen planopilaris.

Licorice root-derived nanoparticles target liver cancer cells to improve treatment and reduce side effects.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

A new AI-driven method shows promise for treating hair loss with a peptide-based drug.

Peptide drugs now target hard-to-reach proteins more effectively and specifically.

PEA-ENL improves skin delivery and reduces inflammation without side effects.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

Finasteride reduces certain behaviors caused by D1-like receptor agonists but not by D2-like receptor agonists in mice.

Lepidium sativum seed extracts helped reduce inflammation and improve insulin response in obese rats on a high-fat diet.

Topical prostaglandin analogues may improve hair density in androgenetic alopecia, but more research is needed.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

The S1PR 1&4 modulator may effectively treat alopecia areata by reducing hair loss and immune cell activity.

Vitamin D3 and parathyroid hormone-related peptide may have important uses in skin treatments.

Ginsenoside compound K shows promise for treating metabolic diseases like obesity and diabetes, but more research is needed on its safety and effectiveness.

Analog 23 is a promising compound for prostate cancer treatment.

PLGA-based microneedles show promise for painless, long-term drug delivery but need design and safety improvements.

2h-ICPR can help screen for insulin antibodies in type 2 diabetes patients.

Alloxan diabetes, methylthiouracil, cortisone, and adrenaline affect how white mice hair follicles use glucose and cystine and their cell division.

New treatments for cancer and skin disorders show promise in disrupting harmful cell interactions and promoting hair growth.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

Mutations in certain receptors can cause diseases and offer new treatment options.

Manipulating 5α-reductase type 2 can affect liver fat production and glucocorticoid effects.

Lifestyle changes are more effective than metformin for reducing type 2 diabetes risk.

New pregnane derivatives are effective at inhibiting an enzyme linked to hair loss and reducing oil gland activity.

Peptide nanoparticles can effectively deliver CRISPR-Cas9 to target KRAS mutations in cancer.

The antibody 005-C04 blocks prolactin receptors, causing reversible infertility, impaired lactation, and hair regrowth in female mice.

Not having the gene PLAAT3 leads to fat loss, high insulin resistance, and abnormal fat levels in the blood due to a disruption in fat cell development and function.

Delivering IGF-1 with PLGA microspheres improves stem cell regeneration for tissues.

The new hyaluronic acid gel is as safe and effective for lip enhancement as the existing product.

Genetically modified stem cells from human hair follicles can lower blood sugar and increase survival in diabetic mice.